<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14-ijerph-17-04951">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hoornenborg</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Coyer</surname>
    <given-names>L.N.</given-names>
   </name>
   <name>
    <surname>Achterbergh</surname>
    <given-names>R.C.A.</given-names>
   </name>
   <name>
    <surname>vanderLoeff</surname>
    <given-names>M.F.S.</given-names>
   </name>
   <name>
    <surname>Bruisten</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>deVries</surname>
    <given-names>H.J.C.</given-names>
   </name>
   <name>
    <surname>AMste</surname>
    <given-names>H.I.V.T.E.</given-names>
   </name>
  </person-group>
  <article-title>High incidence of hepatitis C virus (re-) infections among PrEP users in the Netherlands: Implications for prevention, monitoring and treatment</article-title>
  <source>J. Int. AIDS Soc.</source>
  <year>2018</year>
  <volume>21</volume>
  <fpage>115</fpage>
 </element-citation>
</ref>
